                                                                     UBER TECHNOLOGIES, INC.
                                                        CONSOLIDATED STATEMENTS OF CASH FLOWS
                                                                                (In millions)                                         Year Ended December 31,
                                                                                                                              2019               2020           2021
Proceeds from issuance and sale of subsidiary preferred stock units                                                               1,000                247            675
Proceeds from the issuance of common stock under the Employee Stock Purchase Plan                                                     49               125            107
Issuance of term loan and notes, net of issuance costs                                                                            1,189              2,628          1,484
Principal repayment on term loan and notes                                                                                          (27)              (527)           (27)
Principal repayment on Careem Notes                                                                                                   —               (891)         (307)
Principal payments on finance leases                                                                                               (138)              (224)         (226)
Other financing activities                                                                                                          (34)                38            101
             Net cash provided by financing activities                                                                            8,939              1,379          1,780
Effect of exchange rate changes on cash and cash equivalents, and restricted cash and cash equivalents                                (4)              (92)           (69)
             Net increase (decrease) in cash and cash equivalents, and restricted cash and cash equivalents                       3,824             (4,327)            65
Cash and cash equivalents, and restricted cash and cash equivalents
Beginning of period                                                                                                               8,209            12,067           7,391
Reclassification from (to) assets held for sale during the period                                                                     34              (349)           349
End of period, excluding cash classified within assets held for sale                                                    $        12,067    $         7,391          7,805
Supplemental disclosures of cash flow information
       Cash paid for:
             Interest, net of amount capitalized                                                                        $           332    $           412            449
             Income taxes, net of refunds                                                                                           133                 82             87
       Non-cash investing and financing activities:
             Conversion of redeemable convertible preferred stock to common stock upon initial public
             offering                                                                                                            14,224                 —              —
             Conversion of convertible notes to common stock upon initial public offering                                         4,229                 —              —
             Conversion of convertible notes to common stock related to Careem                                                        —                 —             232
             Finance lease obligations                                                                                              251                196            184
             Common stock issued in connection with acquisitions                                                                       9             3,898          1,868
             Ownership interest received in exchange for divestitures                                                                 —                171          1,018
             Issuance of Careem Notes including the holdback amount                                                                   —              1,634             —
                                        The accompanying notes are an integral part of these consolidated financial statements.
                                                                                      81